Cleared Traditional

K191870 - VV330 Continuous ECG Platform, VivaLNK Adhesive Patch (FDA 510(k) Clearance)

Jan 2020
Decision
179d
Days
Class 2
Risk

K191870 is an FDA 510(k) clearance for the VV330 Continuous ECG Platform, VivaLNK Adhesive Patch. This device is classified as a Transmitters And Receivers, Physiological Signal, Radiofrequency (Class II - Special Controls, product code DRG).

Submitted by VivaLNK, Inc. (Campbell, US). The FDA issued a Cleared decision on January 7, 2020, 179 days after receiving the submission on July 12, 2019.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.2910.

Submission Details

510(k) Number K191870 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 12, 2019
Decision Date January 07, 2020
Days to Decision 179 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code DRG - Transmitters And Receivers, Physiological Signal, Radiofrequency
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.2910